We are saddened by the sudden loss of our colleague Stephen Harrison, especially on the heels of his work that led to the first treatment for #MASH. Watch him discuss his hopes for resmetirom & patients. Our deepest condolences to his family. #livertwitter bit.ly/3JxDZEO
VCU Stravitz-Sanyal Institute for Liver Disease
1,692 posts
The Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at VCU is revolutionizing global health through innovative liver research. 804-828-5066.
- Proud that institute director @ArunJSanyalVCU is among the top cited researchers 🌐. 'Clarivate Reveals World's Influential Researchers in Highly Cited Researchers 2023 List.' He has been on the list since 2017. @VCU @VCUHealth @VCU_CCTR #livertwitter prn.to/3QYYM8P
- Study of #cirrhosis patients led by @JasmohanBajaj in @TheLancet. 'We did not anticipate such a wide disparity in cirrhosis mortality, but it shows that globally we are not on a level playing field when it comes to addressing advanced #liver disease.' bit.ly/3MtVJ5k
- Institute faculty among the top 2% of all scientists worldwide: Stanford rankings. bit.ly/3YrvZh6
- Hello, Twitterverse. For our 1st tweet, we'd like to say that the $104 million gift we received is allowing @VCU and its partners to reinvent the way patients with #liver disease are cared for and to educate future physician-scientists. liverinstitute.medschool.vcu.edu
- .@VCU names pediatric hepatologist @SaulKarpen as the liver institute's first Chief Scientific Officer. Karpen, from @EmoryUniversity, will lead the expansion of research on the liver and metabolic diseases at the institute. bit.ly/3N9s5U8 #livertwitter @AASLDtweets
- Don't miss @jasmohanajaj present the @AASLD Leon Schiff lecture Nov. 18 on Hepatic Encephalopathy! #HE is a devastating and underappreciated complication of cirrhosis that impacts patients, their families, the health care system and society. #livertwitter #TLM24
- Welcoming our incoming gastroenterology fellows to @VCU! We look forward to working with these talented group of individuals and being part of their fellowship journey. @dr_gildea @JTGrady02 @vinayjaha #LiverTwitter #MatchDay
- In @NatRevGastroHep, our @JuanPabloArab reflects on the past, present and future state of #MASLD research and clinical management. He calls for a collaborative model which will ensure comprehensive care. go.nature.com/40FLKCq #livertwitter
- The Institute welcomes @saulkarpen, M.D., Ph.D. He joins the Institute today to lead its research efforts as its first chief scientific officer. bit.ly/48BBs6C #livertwitter #liver
- So pleased to share the news that @jasmohanbajaj was elected to the Association of American Physicians! See the entire list of honorees at aap-online.org #livertwitter
- Our Director of Alcohol Sciences, @juanpabloarab, opines in this new @NatRevGastroHep Viewpoint article, "MASLD: A Disease in Flux," w/ @VWSWong and @AlinaAllenMD. "So excited about all the advances in the field and so many more to come!" #LiverTwitter bit.ly/4dEAUiS
- A recent international study in @HepCommJournal, led by our @juanpabloarab, found that three commonly prescribed corticosteroids offer similar outcomes for patients suffering from severe alcohol-associated hepatitis. bit.ly/3Us7M7W
- We're expanding our international ties to train next generation of #liver specialists. Collaborations in India, Brazil and elsewhere are our latest new partnerships to help hepatologists worldwide fight #NAFLD, #NASH, #MASH. bit.ly/3KELDhP #LiverTwitter #highered














